BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 16842398)

  • 1. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution].
    Couffignal AL; Lapeyre-Mestre M; Bonhomme C; Bugat R; Montastruc JL
    Therapie; 2000; 55(5):635-41. PubMed ID: 11201979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital.
    Durrieu G; Batz A; Rousseau V; Bondon-Guitton E; Petiot D; Montastruc JL
    Eur J Clin Pharmacol; 2014 Dec; 70(12):1519-26. PubMed ID: 25304009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting adverse drug reactions on a geriatric ward: a pilot project.
    Somers A; Petrovic M; Robays H; Bogaert M
    Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the PMSI for the detection of adverse drug reactions].
    Osmont MN; Cuggia M; Polard E; Riou C; Balusson F; Oger E
    Therapie; 2013; 68(4):285-95. PubMed ID: 23981266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitals.
    Osmont MN; Degremont A; Jantzem H; Audouard-Marzin Y; Lalanne S; Carlhant-Kowalski D; Bellissant E; Oger E; Polard E
    Br J Clin Pharmacol; 2021 Feb; 87(2):471-482. PubMed ID: 32484575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
    von Euler M; Eliasson E; Ohlén G; Bergman U
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-infectives-induced adverse drug reactions in hospitalized patients.
    Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions in patients in an Iranian department of internal medicine.
    Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a univeristy hospital in Riyadh.
    Al-Malaq HM; Al-Aqeel SA; Al-Sultan MS
    Saudi Med J; 2008 Aug; 29(8):1145-50. PubMed ID: 18690308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous reporting of adverse drug reactions by nurses.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can the sub-notification of drug adverse effects by capture/recapture method be evaluated?].
    Jonville-Béra AP; Autret E
    Therapie; 1996; 51(2):169-75. PubMed ID: 8763052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
    Okezie EO; Olufunmilayo F
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.